Ignite Creation Date:
2024-05-06 @ 1:37 PM
Last Modification Date:
2024-10-26 @ 1:17 PM
Study NCT ID:
NCT04074993
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-09-28
First Post:
2019-08-25
Brief Title:
Brigatinib in ALK-positive NSCLC Identified Via Blood-based Assays
Sponsor:
Organization:
National Cancer Center Korea